Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Operating Income Growth (3y) (2014 - 2026)

Analysis

Emergent BioSolutions (EBS) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 7.09%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 12.54%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 51.64%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 19.17%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 7.73%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 33.03%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn -15.60%
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 44.54%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 24.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.69%
Mar 31, 2026 27.47%
Dec 31, 2025 20.39%
Sep 30, 2025 54.51%
Jun 30, 2025 26.43%
Mar 31, 2025 93.38%
Dec 31, 2024 -26.68%
Sep 30, 2024 51.00%
Jun 30, 2024 -212.99%
Mar 31, 2024 -24.42%
Dec 31, 2023 -29.46%
Sep 30, 2023 -81.20%
Jun 30, 2023 -62.92%
Mar 31, 2023 -133.46%
Dec 31, 2022 -39.43%
Sep 30, 2022 -38.22%
Jun 30, 2022 -121.72%
Mar 31, 2022 31.07%
Dec 31, 2021 194.75%
Sep 30, 2021 -60.03%
API Access

Emergent BioSolutions Operating Income Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income-growth-3y&ticker=EBS&period=max&api_key=YOUR_API_KEY